- Report
- June 2024
- 150 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- April 2024
- 130 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- March 2024
- 110 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- December 2023
- 150 Pages
Global
From €5911EUR$5,950USD£4,915GBP
- Report
- July 2024
- 144 Pages
Global
From €3873EUR$3,899USD£3,221GBP
- Report
- January 2024
- 200 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- January 2024
- 200 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- November 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
- Report
- October 2024
- 175 Pages
Global
From €4967EUR$5,000USD£4,130GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more